SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer

Rebecca Johnson,1 Nirupama Sabnis,2 Xiangle Sun,1 Ruhani Ahluwalia,3 Andras G Lacko2,4 1Institute of Molecular Medicine, 2Institute for Cardiovascular and Metabolic Diseases, University of North Texas Health Science Center, 3Harmony School of Innovation, 4Department of Pediatrics, University of Nort...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Johnson R, Sabnis N, Sun X, Ahluwalia R, Lacko AG
Format: article
Langue:EN
Publié: Dove Medical Press 2017
Sujets:
Accès en ligne:https://doaj.org/article/f7262946c78546ec9f27e10edded8f4c
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!